NYSE : WST

West Pharmaceutical Services, Inc. — Financial statements

Healthcare · Medical Instruments & Supplies · United States

Last price 412.62 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 28.74B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

West Pharmaceutical Services, Inc. (WST) reported revenue of 3.40B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue3.40B3.07B2.89B2.95B2.89B2.83B
Cost of Revenue2.12B1.97B1.89B1.82B1.75B1.65B
Gross Profit1.28B1.10B998.50M1.13B1.14B1.18B
Selling, General & Admin426.20M389.70M334.90M354.10M316.00M356.30M
Research & Development75.60M74.30M69.10M68.40M58.50M52.80M
Other Operating Expenses-1.90M1.30M900.00K1.30M-2.10M
Operating Expenses499.90M465.30M404.90M423.80M372.40M409.10M
Operating Income777.00M638.70M593.60M706.20M763.80M768.60M
Interest Expense-8.10M-500.00K-3.00M-9.00M-7.90M-8.20M
Interest & Investment Income18.30M17.50M19.60M28.00M5.10M1.00M
Earnings From Equity Investments17.70M14.40M14.70M17.70M20.70M20.10M
Currency Exchange Gain (Loss)-6.70M-8.40M-10.20M-9.40M4.10M1.40M
EBT Excluding Unusual Items798.20M661.70M614.70M733.50M785.80M782.90M
Merger & Restructuring Charges-26.90M-29.50M-2.10M2.00M-23.80M-2.20M
Gain (Loss) on Sale of Investments-8.00M-4.50M-300.00K-4.30M-3.50M-4.30M
Gain (Loss) on Sale of Assets55.70M-11.60M
Asset Writedown-3.40M-3.70M-7.00M-5.30M-2.70M-4.10M
Legal Settlements3.80M
Other Unusual Items-8.50M-8.70M-5.10M-2.40M-55.20M-3.30M
Pretax Income807.10M615.30M600.20M715.70M700.60M769.00M
Income Tax Expense168.20M121.60M107.50M122.30M114.70M107.20M
Net Income638.90M493.70M492.70M593.40M585.90M661.80M
Net Income to Common638.90M493.70M492.70M593.40M585.90M661.80M
Shares Outstanding (Basic)71.40M72.30M73.00M74.30M74.40M74.40M
Shares Outstanding (Diluted)71.80M72.70M73.70M75.30M75.80M76.30M
EPS (Basic)8.956.836.757.997.888.90
EPS (Diluted)8.906.796.697.887.738.67
Free Cash Flow453.40M468.90M276.40M414.50M439.40M330.60M
Free Cash Flow Per Share6.326.453.755.505.804.33
Dividend Per Share0.880.850.810.770.730.69
Gross Margin37.59%35.91%34.51%38.31%39.36%41.59%
Operating Margin22.88%20.78%20.52%23.94%26.46%27.14%
Profit Margin18.81%16.06%17.03%20.12%20.29%23.37%
Free Cash Flow Margin13.35%15.25%9.55%14.05%15.22%11.68%
EBITDA961.30M810.10M749.00M843.50M884.40M890.90M
EBITDA Margin28.30%26.35%25.89%28.59%30.64%31.46%
D&A For EBITDA184.30M171.40M155.40M137.30M120.60M122.30M
EBIT777.00M638.70M593.60M706.20M763.80M768.60M
EBIT Margin22.88%20.78%20.52%23.94%26.46%27.14%
Effective Tax Rate20.84%19.76%17.91%17.09%16.37%13.94%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents464.10M791.30M484.60M853.90M894.30M762.60M
Cash & Short-Term Investments464.10M791.30M484.60M853.90M894.30M762.60M
Receivables763.30M586.30M575.80M533.50M523.70M503.60M
Inventory464.70M443.90M377.00M434.70M414.80M378.40M
Other Current Assets124.40M156.70M100.70M114.30M86.70M97.40M
Total Current Assets1.82B1.98B1.54B1.94B1.92B1.74B
Property, Plant & Equipment1.81B1.88B1.72B1.51B1.26B1.13B
Long-Term Investments215.80M212.30M202.10M210.00M204.90M207.70M
Goodwill108.70M109.90M106.00M108.50M107.30M109.90M
Other Intangible Assets6.20M7.70M10.80M15.10M18.40M23.00M
Long-Term Deferred Tax Assets60.20M38.40M26.00M25.70M65.60M48.50M
Other Long-Term Assets45.40M45.40M44.60M21.30M38.40M55.90M
Total Assets4.06B4.27B3.64B3.83B3.62B3.31B
Accounts Payable249.40M253.70M239.30M242.40M215.40M232.20M
Accrued Expenses162.90M214.60M138.00M161.30M145.80M186.10M
Current Portion of Long-Term Debt134.00M2.20M44.20M
Current Portion of Leases20.90M24.20M18.80M17.70M16.00M9.30M
Current Income Taxes Payable56.20M28.10M31.50M16.60M24.80M26.30M
Current Unearned Revenue51.90M49.60M41.70M57.30M48.70M
Other Current Liabilities154.90M82.40M73.20M58.10M57.50M47.30M
Total Current Liabilities644.30M654.90M550.40M671.80M519.00M594.10M
Long-Term Debt202.90M202.80M202.60M72.80M206.70M208.80M
Long-Term Leases90.10M99.20M83.90M84.50M93.00M63.00M
Long-Term Unearned Revenue1.80M3.60M12.20M10.90M
Pension & Post-Retirement Benefits28.60M29.00M28.20M29.60M28.20M40.50M
Long-Term Deferred Tax Liabilities23.00M23.00M20.50M12.70M14.30M4.90M
Other Long-Term Liabilities103.60M83.30M71.90M64.90M59.80M67.10M
Total Liabilities1.09B1.09B961.10M948.50M931.90M978.40M
Common Stock18.80M18.80M18.80M18.80M18.80M18.80M
Additional Paid-In Capital22.10M120.20M232.20M249.00M
Retained Earnings4.82B4.37B3.96B3.52B2.99B2.46B
Treasury Stock-1.73B-1.11B-1.06B-637.60M-370.90M-229.50M
Comprehensive Income & Other-137.00M-105.50M-258.10M-143.80M-183.00M-159.60M
Shareholders' Equity2.97B3.18B2.68B2.88B2.68B2.34B
Total Liabilities & Equity4.06B4.27B3.64B3.83B3.62B3.31B
Total Debt313.90M326.20M305.30M309.00M317.90M325.30M
Net Cash (Debt)150.20M465.10M179.30M544.90M576.40M437.30M
Net Cash Per Share2.096.402.437.247.605.73
Filing Date Shares Outstanding69.66M72.02M72.30M73.30M74.14M74.28M
Total Common Shares Outstanding69.80M72.00M72.30M73.50M74.10M74.20M
Working Capital1.17B1.32B987.70M1.26B1.40B1.15B
Book Value Per Share42.5244.1137.1039.2036.2331.47
Tangible Book Value2.85B3.06B2.57B2.76B2.56B2.20B
Tangible Book Value Per Share40.8842.4835.4837.5234.5429.68
Land29.20M27.90M33.70M29.00M29.30M
Buildings1.18B916.10M771.50M663.60M644.80M
Machinery1.76B1.63B1.52B1.39B1.30B
Construction In Progress256.70M410.80M415.20M305.90M242.70M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income638.90M493.70M492.70M593.40M585.90M661.80M
Depreciation & Amortization184.30M171.40M155.40M137.30M120.60M122.30M
Loss (Gain) From Sale of Assets-55.70M11.60M
Asset Writedown & Restructuring Costs18.60M17.10M7.30M9.60M21.50M5.60M
Loss (Gain) on Equity Investments-10.50M-10.50M-13.40M-14.30M-18.10M-17.40M
Stock-Based Compensation28.50M23.80M18.70M23.30M23.70M37.50M
Other Operating Activities-23.10M-20.50M-10.20M36.00M5.40M-27.70M
Change in Accounts Receivable6.90M6.90M-58.80M4.00M-35.60M-123.50M
Change in Inventory-62.80M-62.80M42.00M-13.50M-49.80M-86.50M
Change in Accounts Payable17.90M17.90M2.90M4.40M-2.80M16.80M
Change in Other Net Operating Assets-88.50M117.80M16.80M-15.30M73.20M-4.90M
Operating Cash Flow654.50M754.80M653.40M776.50M724.00M584.00M
Capital Expenditures-201.10M-285.90M-377.00M-362.00M-284.60M-253.40M
Cash Acquisitions-2.20M
Other Investing Activities-8.90M-1.70M-6.70M-3.60M2.50M
Investing Cash Flow-83.10M-285.90M-378.70M-368.70M-288.20M-253.10M
Long-Term Debt Issued164.70M
Total Debt Issued50.00M164.70M
Long-Term Debt Repaid-1.10M-192.30M-2.40M-44.30M-2.20M
Total Debt Repaid-51.50M-1.10M-192.30M-2.40M-44.30M-2.20M
Net Debt Issued (Repaid)-1.50M-1.10M-27.60M-2.40M-44.30M-2.20M
Issuance of Common Stock27.40M18.20M32.70M51.00M28.20M37.10M
Repurchase of Common Stock-689.30M-136.80M-566.60M-451.20M-222.20M-151.90M
Common Dividends Paid-62.80M-61.20M-59.10M-57.00M-54.10M-51.10M
Other Financing Activities-800.00K-4.20M-2.00M-1.20M
Financing Cash Flow-727.00M-185.10M-622.60M-459.60M-293.60M-168.10M
Foreign Exchange Rate Adjustments-8.80M22.90M-21.40M11.40M-10.50M-15.70M
Net Cash Flow-164.40M306.70M-369.30M-40.40M131.70M147.10M
Free Cash Flow453.40M468.90M276.40M414.50M439.40M330.60M
Free Cash Flow Margin13.35%15.25%9.55%14.05%15.22%11.68%
Free Cash Flow Per Share6.326.453.755.505.804.33
Levered Free Cash Flow345.56M273.88M206.72M196.35M246.54M210.05M
Unlevered Free Cash Flow350.62M274.19M208.60M201.97M251.47M215.18M
Cash Interest Paid300.00K300.00K500.00K6.00M6.60M8.00M
Cash Income Tax Paid125.20M125.20M71.40M90.80M109.70M171.80M
Change in Working Capital-126.50M79.80M2.90M-20.40M-15.00M-198.10M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization28.41B19.79B23.72B26.05B17.42B34.74B
Enterprise Value28.26B19.47B23.54B25.46B16.99B34.37B
Last Close Price412.62274.50325.74349.33232.94463.09
PE Ratio45.8140.0948.1543.9129.7452.50
Forward PE40.8736.6945.9042.2334.8453.55
PS Ratio8.446.448.208.836.0412.27
PB Ratio9.706.238.849.046.4914.88
P/TBV Ratio10.046.479.259.456.8115.78
P/FCF Ratio63.2042.2285.8362.8539.65105.09
P/OCF Ratio43.7826.2336.3133.5524.0759.49
PEG Ratio2.693.065.255.392.312.37
EV/Sales Ratio8.396.338.148.635.8912.14
EV/EBITDA Ratio29.6524.0331.4330.1819.2238.58
EV/EBIT Ratio36.6830.4839.6636.0522.2544.72
EV/FCF Ratio62.8641.5285.1761.4338.68103.97
Debt / Equity Ratio0.110.100.110.110.120.14
Debt / EBITDA Ratio0.310.380.390.350.350.36
Debt / FCF Ratio0.690.701.100.740.720.98
Net Debt / Equity Ratio-0.05-0.15-0.07-0.19-0.21-0.19
Net Debt / EBITDA Ratio-0.16-0.57-0.24-0.65-0.65-0.49
Net Debt / FCF Ratio-0.33-0.99-0.65-1.31-1.31-1.32
Asset Turnover0.830.780.770.790.830.93
Inventory Turnover4.704.804.674.284.414.73
Quick Ratio1.912.101.932.062.732.13
Current Ratio2.823.022.792.883.702.93
Return on Equity (ROE)21.23%16.86%17.71%21.32%23.34%31.59%
Return on Assets (ROA)11.89%10.09%9.93%11.86%13.78%15.73%
Return on Invested Capital (ROIC)21.62%19.66%20.14%26.35%31.89%38.14%
Return on Capital Employed (ROCE)22.70%17.70%19.20%22.40%24.70%28.30%
Earnings Yield2.18%2.49%2.08%2.28%3.36%1.91%
FCF Yield1.58%2.37%1.17%1.59%2.52%0.95%
Dividend Yield0.26%0.31%0.25%0.22%0.31%0.15%
Payout Ratio10.33%12.40%12.00%9.61%9.23%7.72%
Buyback Yield / Dilution1.47%1.36%2.12%0.66%0.66%-0.66%
Total Shareholder Return1.73%1.67%2.37%0.88%0.97%-0.51%